Carregant...
Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate
OBJECTIVES: We previously reported vicriviroc (VCV) resistance in an HIV-infected subject and used deep sequencing and clonal analyses to track the evolution of V3 sequence forms over 28 weeks of therapy. Here, we test the contribution of gp120 mutations to CCR5 antagonist resistance and investigate...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3070184/ https://ncbi.nlm.nih.gov/pubmed/20856130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3181f25574 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|